Endoparasite control agent and method for using the same

US10017490B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10017490-B2
Application numberUS-201615267139-A
CountryUS
Kind codeB2
Filing dateSep 15, 2016
Priority dateAug 30, 2012
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide a novel endoparasite control agent as a parasiticide, an antiprotozoal or the like. Provided is an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): or a salt thereof as an active ingredient.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for controlling endoparasites, comprising orally or parenterally administering an effective amount of an endoparasite control composition comprising a compound of the general formula (I): wherein each X may be the same or different, and represents a halogen atom; a cyano group; a nitro group; an amino group; a (C 1 -C 6 ) alkyl group; a halo (C 1 -C 6 ) alkyl group; a (C 1 -C 6 ) alkoxy group; a halo (C 1 -C 6 ) alkoxy group; a (C 1 -C 6 ) alkylthio group; a halo (C 1 -C 6 ) alkylthio group; a (C 1 -C 6 ) alkylsulfinyl group; a halo (C 1 -C 6 ) alkylsulfinyl group; a (C 1 -C 6 ) alkylsulfonyl group; or a halo (C 1 -C 6 ) alkylsulfonyl group, m represents an integer of to 1 or 2, A is a moiety represented by one of the following A1 to A7: E represents a hydrogen atom; a (C 1 -C 6 ) alkyl group; a (C 3 -C 6 ) cycloalkyl group; a (C 1 -C 6 ) alkoxy (C 1 -C 6 ) alkyl group; a (C 1 -C 6 ) alkylcarbonyl group; or a (C 1 -C 6 ) alkoxycarbonyl group, and B represents a moiety represented by B1: wherein each Y may be the same or different, and represents a halogen atom; a heterocycloxy group; or a substituted heterocycloxy group having one or more substituents selected from a halogen atom; and a halo (C 1 -C 6 ) alkyl group, n represents an integer of 0 to 5, and the numbers on each ring represent positions where the ring can be substituted by Y and the free bond extending from each ring is a bond between A and B, or a salt thereof as an active ingredient to a non-human mammal or a bird, wherein the endoparasite belongs to the scope of order Strongylida or Ascaridida. 2. The method according to claim 1 , wherein the endoparasite control composition is administered orally or parenterally to a non-human mammal. 3. The method according to claim 2 , wherein the non-human mammal is a domestic animal. 4. The method according to claim 1 , wherein A is A1, A2 or A3. 5. The method according to claim 1 , wherein the compound of the general formula (I) is a compound of the formula:

Assignees

Inventors

Classifications

  • Anthelmintics · CPC title

  • Antiparasitic agents · CPC title

  • Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis · CPC title

  • One oxygen or sulfur atom · CPC title

  • having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10017490B2 cover?
An object of the present invention is to provide a novel endoparasite control agent as a parasiticide, an antiprotozoal or the like. Provided is an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): or a salt thereof as an active ingredient.
Who is the assignee on this patent?
Univ Tokyo, Nihon Nohyaku Co Ltd
What technology area does this patent fall under?
Primary CPC classification A61K31/166. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).